Advanced search
Publication Cover
Hematology Volume 24, 2019 - Issue 1
Submit an article Journal homepage
2,389
Views
3
CrossRef citations to date
0
Altmetric
Articles

Efficacy and tolerability of rituximab and reduced-dose cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy for elderly patient with diffuse large B-cell lymphoma

Kensuke KayamoriDepartment of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan;Department of Hematology, Chiba University Hospital, Chiba, JapanCorrespondence[email protected]
,
Katsuhiro ShonoDepartment of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan
,
Masahiro OnodaDepartment of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan
&
Akira YokotaDepartment of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan
Pages 52-59 | Published online: 11 Aug 2018

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Dongdong Zhang, Youhong Dong & Liling Zhang. (2023) Bendamustine plus Rituximab versus R-miniCHOP: which is better for unfit patients with diffuse larger B-cell lymphoma?. Journal of Chemotherapy 0:0, pages 1-3.
Read now

Articles from other publishers (2)

Marguerite Briand, Stephane Gerard, Martin Gauthier, Marie Garric, Zara Steinmeyer & Laurent Balardy. (2021) Impact of therapeutic management and geriatric evaluation on patient of eighty years and older with diffuse large B‐cell lymphoma on survival: A systematic review. European Journal of Haematology 108:1, pages 3-17.
Crossref
Alda Tavares & Ilídia Moreira. (2021) Diffuse large B-cell lymphoma in very elderly patients: Towards best tailored treatment – A systematic review. Critical Reviews in Oncology/Hematology 160, pages 103294.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.